|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs and discounts | |||||
| Loss on early extinguishment of debt and write-off of discounts and debt issuance costs | |||||
| Deferred income tax provision | |||||
| Equity-based compensation | |||||
| Other including loss on impairment or disposal of assets, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued salaries, wages and benefits | |||||
| Deferred revenue | |||||
| Other accrued liabilities | |||||
| Right-of-use assets and operating lease liabilities | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Capital expenditures | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from the issuance of debt, net | |||||
| Repayments of long-term debt | |||||
| Proceeds from draw on revolving credit facility | |||||
| Repayments of revolving credit facility | |||||
| Purchase of treasury stock, including related excise tax paid | |||||
| Payment of tax withholdings on equity-based compensation through shares withheld | |||||
| Exercise of stock options | |||||
| Debt issuance costs | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Change in Cash and Cash Equivalents, including Restricted Cash | |||||
| Cash and Cash Equivalents, including Restricted Cash—Beginning of year | |||||
| Cash and Cash Equivalents, including Restricted Cash—End of year | |||||
| Supplemental Disclosures of Noncash Investing and Financing Activities | |||||
| Capital expenditures in accounts payable and accrued expenses | |||||
| Excise tax accrued on treasury stock repurchases | |||||
| Treasury stock purchases not yet settled in accounts payable and accrued expenses | |||||
Loading...